Healixa Health Care Signs Initial Revenue Contracts
Healixa Health Care Signs Initial Revenue Contracts
Manhattan, NY, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water and green-tech industries today announces that it has signed its initial revenue contracts for its AdvocateCare™ subsidiary.
紐約曼哈頓，2022年11月10日(Global Newswire)--Healixa，Inc.(場外交易代碼：EMOR)(“Healixa”，或“公司”)，一家專注於在健康技術、清潔水和綠色技術行業建立和收購創新和顛覆性技術的技術公司今天宣佈，它已經簽署了其AdvocateCare™子公司的初步收入合同。
"Our company is excited to have such a strong opportunity in this very lucrative area. Our approach to Care Management is unique since we are focused on providing proactive holistic preventative care and wellness solutions with cutting edge technology, and analytics which produce enhanced care models and reduce costs of care making today's announcement very significant" said Healixa's CEO Ian Parker.
Healixa首席執行官伊恩·帕克表示：“我們公司很高興在這個非常有利可圖的領域擁有如此強大的機會。我們的護理管理方法是獨一無二的，因為我們專注於提供具有尖端技術的前瞻性整體預防性護理和健康解決方案，以及產生增強護理模式和降低護理成本的分析，這使得今天的聲明具有非常重要的意義。”
AdvocateCare™ uniquely combines personalized patient engagement, wellness, technology, and analytics that result in high touch patient models enriching the patient, provider & payor relationships while including pharmacies as part of the global care management team. Our approach benefits all by reducing the cost of care, creating new recurring revenue streams and increasing the quality of life.
AdvocateCare™獨一無二地將個性化的患者參與、健康、技術和分析結合在一起，從而產生豐富患者、提供者和付款人關係的高接觸患者模型，同時將藥房納入全球護理管理團隊。我們的方法通過降低護理成本、創造新的經常性收入來源和提高生活質量而使所有人受益。
AdvocateCare™ Services:
AdvocateCare™服務：
- Remote Patient Monitoring (RPM)
- Chronic Care Management (CCM)
- Annual Wellness Visits (AWV)
- Medication Therapy Management (MTM)
- Transitional Care Management
- Behavioral Health
- Revenue Cycle Management
- 遠程患者監護(RPM)
- 慢性護理管理(CCM)
- 年度健康訪問(AWV)
- 藥物治療管理(MTM)
- 過渡期護理管理
- 行為健康
- 收入週期管理
Diane Koontz, President of Healixa Health Care said, "The successful launch of our AdvocateCare™ offering shows the demand for services that help Medical Providers enhance patient care while simultaneously reducing burden on staff and improving profitability." She added, "Our unique approach to care management includes pharmacy services so we are better positioned to improve communications between the provider, pharmacy and patient all while improving medication adherence and patient outcomes."
Healixa Healixa Health Care的總裁表示：“我們成功推出了AdvocateCare™服務，這表明了人們對服務的需求，這些服務可以幫助醫療服務提供商加強患者護理，同時減輕員工的負擔並提高盈利能力。”她補充説，“我們獨特的護理管理方法包括藥房服務，因此我們能夠更好地改善提供者、藥房和患者之間的溝通，同時提高用藥依從性和患者結果。”
About Healixa Health Care:
Healixa Health Care簡介：
Healixa Health Care, A subsidiary of Healixa, Inc, is focused on healing and easing the burden of accessing healthcare through innovative technological solutions and services that benefit all stakeholders, patients, pharmacies and providers. Healixa HC recognizes that the future of care delivery is evolving to become more patient-centric, virtual, in the home and value driven. By applying the latest AI digital technology, Healixa Healthcare can simplify processes, streamline communications, and strengthen partnerships across the full spectrum of healthcare.
Healixa Health Care是Healixa，Inc.的子公司，專注於通過創新的技術解決方案和服務來治癒和減輕獲得醫療保健的負擔，使所有利益相關者、患者、藥店和提供者受益。Healixa HC認識到，未來的護理服務正在演變為更加以患者為中心、虛擬的、家庭的和價值驅動的。通過應用最新的人工智能數字技術，Healixa Healthcare可以簡化流程、簡化通信並加強醫療保健全領域的合作伙伴關係。
About Healixa
關於Healixa
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries. Healixa embraces innovation by combining its intellectual properties, patents, strategic collaborations, and partnerships to create a "LaunchPad" of disruptive sustainable products.
Healixa是一家科技公司，專注於在健康科技、清潔水發電和綠色科技行業建立和收購創新和顛覆性技術。Healixa擁抱創新，將其知識產權、專利、戰略合作和合作夥伴關係結合在一起，創建了一個顛覆性可持續產品的“發射臺”。
Forward-looking Statements
前瞻性陳述
Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
本新聞稿中包含的某些陳述可能構成前瞻性陳述。例如，在討論我們預期的研發計劃等時，會使用前瞻性陳述。這些前瞻性陳述僅基於對管理層的當前預期，受重大風險和不確定因素的影響，這些風險和不確定因素可能導致實際結果與前瞻性陳述中描述的大不相同，包括但不限於與合作伙伴關係和產品開發計劃的進度、時間、成本和結果有關的風險和不確定因素；在獲得監管批准或專利保護方面的困難或延遲；以及來自其他公司的競爭。除非法律另有要求，Healixa，Inc.沒有義務公開發布對這些前瞻性陳述的任何修訂，以反映本前瞻性陳述之後的事件或情況，或反映意外事件的發生。
Healixa, Inc. Contact
Healixa，Inc.聯繫人
Bret Hedges
SVP of Strategic Partnerships
833-432-5492
Bret@healixa.com
Bret Hedge
戰略合作伙伴關係高級副總裁
833-432-5492
郵箱：bret@healixa.com
譯文內容由第三人軟體翻譯。